Story perspectives

Biotech Firms Award Stock Options to New Hires

4/12/2025

46 4

Summary

Story summary

Nurix Therapeutics awarded inducement stock options for 79,950 shares and RSUs for 54,750 shares to 16 new employees, effective April 8, 2025.
Ocular Therapeutix granted inducement stock options and RSUs to new hires, including Executive Director Thomas J. Cella, effective April 7, 2025.
Fulcrum Therapeutics issued stock options totaling 96,800 options at $2.72 per share to two new employees, effective April 7, 2025.
Replimune Group provided inducement equity awards to 53 new employees, including options for 98,450 shares and RSUs for 155,875 shares, effective April 7, 2025.

1 of 1

Story summary

Nurix Therapeutics awarded inducement stock options for 79,950 shares and RSUs for 54,750 shares to 16 new employees, effective April 8, 2025.
Ocular Therapeutix granted inducement stock options and RSUs to new hires, including Executive Director Thomas J. Cella, effective April 7, 2025.
Fulcrum Therapeutics issued stock options totaling 96,800 options at $2.72 per share to two new employees, effective April 7, 2025.
Replimune Group provided inducement equity awards to 53 new employees, including options for 98,450 shares and RSUs for 155,875 shares, effective April 7, 2025.